About Sobi

Sobi is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families.

We have a diversified and growth-oriented commercial product portfolio. Key therapeutic areas are Inflammation and Genetics & Metabolism. Our Partner Product Portfolio areas includes amongst others Oncology, Surgery and Thalassemia. Our late stage pipeline includes three phase III programs with substantial potential. We have world-class capabilities in protein biochemistry and biologics manufacturing development - validated by leading industry partners. Global reachOur sales and marketing organization covers about 20 countries in Europe and a subsidiary in the US. We are also represented through partners in in the Middle East, Australia and New Zealand. Swedish Orphan Biovitrum develops, manufactures and sells medications for a number of diseases, with a special emphasis on four specialist areas: haemophilia, inflammation/autoimmune diseases, inherited metabolic diseases and oncology.

PatientsWe focus on medications for rare disease patients with a high unmet medical need. This category includes specialist and so-called orphan drugs, which are mainly prescribed by clinical specialists and aimed at small well-defined patient groups. These less common diseases are often neglected and inadequately treated which means that new medications can offer significant value for the patient and health care providers.

Meet the Sobi Account Managers


More news


medical sales    pharmaceutical sales    medical sales jobs    pharmaceutical sales jobs    laboratory sales    scientific sales    nurse advisor    veterinary sales    biotechnology jobs    uk medical sales